UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

The New England journal of medicine, 2021-11, Vol.385 (20), p.1845-1855

2021

Volltextzugriff (PDF)

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

Heart, lung & circulation, 2018-10, Vol.27 (10), p.1123-1208

2018

Volltextzugriff (PDF)

Pulmonary Hypertension and Right Heart Dysfunction in Chronic Lung Disease

BioMed research international, 2014-01, Vol.2014, p.739674-13

2014

Volltextzugriff (PDF)

Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

The American heart journal, 2023-12, Vol.266, p.25-31

2023

Volltextzugriff (PDF)

Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension

Journal of cardiovascular magnetic resonance, 2021-03, Vol.23 (1), p.22-22, Article 22

2021

Volltextzugriff (PDF)

Heart Failure With Normal Ejection Fraction: The Complementary Roles of Echocardiography and CMR Imaging

JACC. Cardiovascular imaging, 2010-04, Vol.3 (4), p.409-420

2010

Volltextzugriff (PDF)

Pulmonary Effects of Chronic Elevation in Microvascular Pressure Differ Between Hypertension and Myocardial Infarct Induced Heart Failure

Heart, lung & circulation, 2015-02, Vol.24 (2), p.158-164

2015

Volltextzugriff (PDF)

Systemic inflammation and cell activation reflects morbidity in chronic heart failure

Cytokine (Philadelphia, Pa.), 2011-12, Vol.56 (3), p.593-599

2011

Volltextzugriff (PDF)

Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial

ESC Heart Failure, 2021-10, Vol.8 (5), p.4346-4352

2021

Volltextzugriff (PDF)

Proteína surfactante tipo B en la insuficiencia cardiaca crónica: un examen de la barrera alveolocapilar

Revista española de cardiologia, 2009-02, Vol.62 (2), p.117-119

De Pasquale, Carmine G

2009

Volltextzugriff (PDF)

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

The New England journal of medicine, 2023-09, Vol.389 (11), p.975-986

2023

Volltextzugriff (PDF)

Impact of increased augmentation index and valvuloarterial impedance on symptom recovery after aortic valve replacement for severe aortic stenosis

International journal of cardiology. Heart & vasculature, 2021-02, Vol.32, p.100705-100705, Article 100705

2021

Volltextzugriff (PDF)

Mild cognitive impairment predicts death and readmission within 30days of discharge for heart failure

International journal of cardiology, 2016-10, Vol.221, p.212-217

2016

Volltextzugriff (PDF)

Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis

Cytokine (Philadelphia, Pa.), 2023-01, Vol.161, p.156060-156060, Article 156060

2023

Volltextzugriff (PDF)

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018

Medical journal of Australia, 2018-10, Vol.209 (8), p.363-369

2018

Volltextzugriff (PDF)

Mild cognitive impairment predicts death and readmission within 30 days of discharge for heart failure

International journal of cardiology, 2016-10

2016

Volltextzugriff (PDF)

PO-03-079 ELECTROPHYSIOLOGIC CHARACTERISATION OF ATRIAL FIBRILLATION IN THE PRESENCE OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Heart rhythm, 2024-05, Vol.21 (5), p.S398-S398

2024

Volltextzugriff (PDF)

Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design

Circulation. Heart failure, 2021-05, Vol.14 (5), p.e008100-e008100

2021

Volltextzugriff (PDF)

The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial

Circulation (New York, N.Y.), 2022-12, Vol.146 (23), p.1749-1757

2022

Volltextzugriff (PDF)

Nutraceuticals in Patients With Heart Failure: A Systematic Review

Journal of cardiac failure, 2020-02, Vol.26 (2), p.166-179

2020

Volltextzugriff (PDF)

The Spectrum of Change in the Elite Athlete's Heart

Journal of the American Society of Echocardiography, 2019-08, Vol.32 (8), p.978-986

2019

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors in South Australia: The Magic Before the Fame

Heart, lung & circulation, 2023-11, Vol.32 (11), p.1369-1377

2023

Volltextzugriff (PDF)

Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial

Circulation. Heart failure, 2024-02, Vol.17 (2), p.e010676

2024

Volltextzugriff (PDF)

Accuracy of Highly Limited Echocardiographic Screening Images for Determining a Structurally Normal Heart: The Quick-Six Study

Heart, lung & circulation, 2022-04, Vol.31 (4), p.462-468

2022

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(103)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

Pulmonary Hypertension and Right Heart Dysfunction in Chronic Lung Disease

Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension

Heart Failure With Normal Ejection Fraction: The Complementary Roles of Echocardiography and CMR Imaging

Pulmonary Effects of Chronic Elevation in Microvascular Pressure Differ Between Hypertension and Myocardial Infarct Induced Heart Failure

Systemic inflammation and cell activation reflects morbidity in chronic heart failure

Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial

Proteína surfactante tipo B en la insuficiencia cardiaca crónica: un examen de la barrera alveolocapilar

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Impact of increased augmentation index and valvuloarterial impedance on symptom recovery after aortic valve replacement for severe aortic stenosis

Mild cognitive impairment predicts death and readmission within 30days of discharge for heart failure

Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018

Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART ‐ FID

Mild cognitive impairment predicts death and readmission within 30 days of discharge for heart failure

PO-03-079 ELECTROPHYSIOLOGIC CHARACTERISATION OF ATRIAL FIBRILLATION IN THE PRESENCE OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design

The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial

Nutraceuticals in Patients With Heart Failure: A Systematic Review

The Spectrum of Change in the Elite Athlete's Heart

Sodium-Glucose Cotransporter 2 Inhibitors in South Australia: The Magic Before the Fame

Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial

Accuracy of Highly Limited Echocardiographic Screening Images for Determining a Structurally Normal Heart: The Quick-Six Study

Aktive Filter

Suchergebnisse filtern